Genomics Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 624 Deals Signed Since 2018 by Company A-Z, Financial Terms, Deal Type and Therapeutic Target
January 03, 2025 11:16 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2018-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Viral Vector Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 396 Deals Signed Since 2016 by Company A-Z, Financial terms, Deal Type and Therapy Focus
January 03, 2025 11:07 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Precision Medicine in Oncology Collaboration and Licensing Deals Analysis Report 2024 with Directory of 821 Deals Signed Since 2016 by Company A-Z, Deal Type and Therapeutic Target
January 03, 2025 10:59 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report...
Biologics Contract Manufacturing Market Industry Report 2024-2035: Mammalian Expression System is Set to Capture the Highest Share of the Market During the Forecast Period
December 23, 2024 12:59 ET
|
Research and Markets
Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type...
Biopreservation Market to Accelerate at 18.2% CAGR, Reaching Revenues of US$24.5 Billion by 2033
December 20, 2024 06:43 ET
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Biopreservation Market: Global Forecast by Product, Application, Countries and Company Analysis" report has been added to ResearchAndMarkets.com's...
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
December 19, 2024 17:05 ET
|
AVITA Medical
AVITA Medical announces FDA clearance for Cohealyx, a new collagen-based dermal matrix, expanding its addressable market.
Regenerative Medicine Research Report 2024-2031: Approvals for New Regenerative Medicines and Increasing Applications of Regenerative Medicine in Newer Therapy Areas Driving the $37.27 Billion Market
December 19, 2024 05:24 ET
|
Research and Markets
Dublin, Dec. 19, 2024 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product Application End User - Global Forecast to 2031" report has been...
Longeveron to Present at Biotech Showcase 2025
December 18, 2024 09:10 ET
|
Longeveron
Longeveron Chief Executive Officer Wa’el Hashad will give a corporate presentation at Biotech Showcase, being held January 13-15, 2025.
Organoids Market Outlook 2024-2029: Increasing Demand for Tumor Modeling and Biobanking, Growing Adoption of Personalized Drugs and Rising Focus on Developing Alternatives for Animal Testing Models
December 17, 2024 08:47 ET
|
Research and Markets
Dublin, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The "Organoids Market: Analysis By Organ Type, By Application, By Source, By Type, By End-User, By Region Size and Trends and Forecast up to 2029" report...
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine
December 17, 2024 08:00 ET
|
Evergen
ALACHUA, Fla., December 17, 2024 – RTI Surgical ("the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, today...